McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
McKesson (MCK) closed at $530.27 in the latest trading session, marking a -0.16% move from the prior day.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.